The Present and Future of Tysabri
Our thoughts are with the patients and families in Europe who recently developed PML (Progressive Multifocal Leukoencephalopathy) on Natalizumab (Tysabri®). When Tysabri® was being developed a few years ago, there was a lot of hope in the MS Community about the idea of a non injectable disease modifying agent for the... Read more









